Harbor Advisors LLC Zai Lab LTD Transaction History

Harbor Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 29, 2021	SELL	$105.0 - $178.37 $315,000 - $535,110	-3,000 Closed	0 $0
Q2 2020 Aug 03, 2020	SELL	$48.82 - $82.53 $146,460 - $247,590	-3,000 Reduced 50.0%	3,000 $246,000
Q4 2019 Feb 13, 2020	BUY	$29.79 - $43.06 $178,740 - $258,360	6,000 New	6,000 $250,000
Q3 2019 Nov 13, 2019	SELL	$30.47 - $37.65 $182,820 - $225,900	-6,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$25.73 - $35.79 $154,380 - $214,740	6,000 New	6,000 $209,000

116

40.8M

63.1K

420K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.02B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Harbor Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Harbor Advisors LLC with notifications on news.